Crispr Therapeutics shares tumble after significant earnings miss
ALISO VIEJO, Calif. - indie Semiconductor, Inc. (NASDAQ:INDI) reported in-line fourth quarter earnings and revenue but issued disappointing guidance, sending shares down 4.9% in after-hours trading.
The automotive solutions innovator posted Q4 non-GAAP earnings per share of -$0.07, matching analyst estimates. Revenue came in at $58 million, slightly below the consensus of $58.04 million but up 7.5% sequentially.
However, indie’s outlook for the first quarter fell short of expectations. The company forecasts Q1 2025 revenue between $52.5 million and $57.5 million, below the $61.3 million analysts were projecting. At the midpoint of $55 million, this guidance represents a 5.2% sequential decline but a 5.1% YoY increase.
CEO Donald McClymont cited a "challenging market backdrop" but emphasized the company’s "resilient business performance" in Q4. He stated, "This technology leadership position will also ensure that we drive growth throughout 2025 and beyond."
indie reported a Q4 non-GAAP gross margin of 50.4%, flat compared to the previous quarter. For Q1, the company expects non-GAAP gross margin between 49% and 50%.
The company highlighted several business achievements, including being on track for initial volume shipments of flagship ADAS programs in the second half of 2025 and securing new design wins for its vision processor with multiple OEMs.
Despite the weaker-than-expected guidance, indie remains optimistic about its prospects, citing strong design win momentum and key program status throughout 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.